Trump Announces New Drug Pricing Deals

The Trump administration has announced new drug pricing agreements with several pharmaceutical companies and smaller biotechs. Participating firms will offer medications to state Medicaid programs at lower prices, though specific savings remain unclear.

Xurve View
Insights:
U.S. Secretary of Commerce Howard Lutnick, U.S. Secretary of Health and Human Services Robert F. Kennedy Jr., and U.S. Center for Medicare & Medicaid Services Administrator Dr. Mehmet Oz stand behind U.S. President Donald Trump in the Oval Office

United States President Donald Trump secured new drug-pricing agreements with six international pharmaceutical companies on Monday afternoon. The deals aim to lower prescription costs for Medicaid participants nationwide. Administration officials hope to curb healthcare spending before upcoming congressional elections.